Lista de obras - Youchun Wang - Dominio Público Uruguay

A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV

scholarly article by Changfa Fan published in August 2018

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

artículo científico publicado en 2021

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

artículo científico publicado en 2022

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

artículo científico publicado en 2020

Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains

artículo científico publicado en 2022

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron BA.1 infection

artículo científico publicado en 2022

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

artículo científico publicado en 2022

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

artículo científico publicado en 2022

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus

artículo científico publicado en 2016

Effect of the maturation of neutralizing antibodies on human immunodeficiency virus (HIV) envelope evolution in HIV-infected subjects

artículo científico publicado en 2015

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

artículo científico publicado en 2024

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses

artículo científico publicado en 2021

HIV-1 pseudoviruses constructed in China regulatory laboratory

scientific article published on 20 December 2019

Human neutralizing antibodies elicited by SARS-CoV-2 infection

artículo científico publicado en 2020

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

artículo científico publicado en 2021

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

artículo científico publicado en 2022

Monitoring Neutralization Property Change of Evolving Hantaan and Seoul Viruses with a Novel Pseudovirus-Based Assay

artículo científico publicado en 2020

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

artículo científico publicado en 2021

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

artículo científico publicado en 2020

RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA.

artículo científico publicado en 2017

Screening and Identification of Marburg Virus Entry Inhibitors Using Approved Drugs

artículo científico publicado en 2019

Screening and evaluation of potential inhibitors against vaccinia virus from 767 approved drugs

artículo científico publicado en 2019

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

scientific article published on 16 November 2020

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

artículo científico publicado en 2020

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

artículo científico publicado en 2020

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

artículo científico publicado en 2021

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

artículo científico publicado en 2021

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

artículo científico publicado en 2022

Lista de obras de Youchun Wang

A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron BA.1 infection

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus

Effect of the maturation of neutralizing antibodies on human immunodeficiency virus (HIV) envelope evolution in HIV-infected subjects

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses

HIV-1 pseudoviruses constructed in China regulatory laboratory

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

Monitoring Neutralization Property Change of Evolving Hantaan and Seoul Viruses with a Novel Pseudovirus-Based Assay

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA.

Screening and Identification of Marburg Virus Entry Inhibitors Using Approved Drugs

Screening and evaluation of potential inhibitors against vaccinia virus from 767 approved drugs

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain